Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...
"ITERUM" (until June 6, 2024 - "PET Baltija") is one of the largest polyethylene terephthalate (PET) processing companies in Northern Europe and the largest PET processing company in the Baltic region ...
DUBLIN and CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and ...